0
0
Stevia, a common natural sweetener, shows promising potential in fighting pancreatic cancer cells in laboratory tests, according to recent research from Hiroshima University in Japan. Scientists found that stevia leaf extract fermented with a specific bacterium could selectively kill pancreatic cancer cells without harming healthy kidney cells, marking an exciting advance in the search for safer and more effective cancer therapies.
Stevia’s Anticancer Potential Uncovered
Pancreatic cancer remains one of the deadliest cancers globally, with a five-year survival rate under 10%. Its invasive nature and resistance to conventional treatments such as chemotherapy and radiotherapy make it critical to find novel therapeutic approaches. Researchers at Hiroshima University, led by associate professor Narandalai Danshiitsoodol and professor Masanori Sugiyama, explored natural compounds that could offer new options.
They discovered that fermenting stevia leaf extract using the bacterium Lactobacillus plantarum SN13T—isolated from banana leaves—transforms the extract into a potent anticancer agent. This fermentation process produces bioactive compounds like chlorogenic acid methyl ester (CAME), which significantly inhibit pancreatic cancer cell growth in vitro.
Key Research Findings
The study, published in the International Journal of Molecular Sciences, demonstrated that fermented stevia leaf extract (FSLE) effectively:
-
Killed pancreatic cancer cells (PANC-1) while sparing healthy human embryonic kidney (HEK-293) cells.
-
Induced cancer cell apoptosis (programmed cell death) and arrested the cell cycle in the G0/G1 phase.
-
Upregulated pro-apoptotic genes such as Bax, Bad, Caspase-3/9, Cytochrome c, and E-cadherin, while downregulating anti-apoptotic Bcl-2 gene expression.
-
Inhibited cancer cell migration, which is critical for metastasis prevention.
These findings suggest that CAME, the key metabolite formed during fermentation, disrupts the survival mechanisms of pancreatic cancer cells, making FSLE a promising candidate for further study.
Expert Perspectives on the Findings
Dr. Paul E. Oberstein, medical oncologist at NYU Langone Perlmutter Cancer Center, expressed cautious optimism, highlighting the increased potency of the fermented extract compared to non-fermented stevia. He emphasized the importance of validating these laboratory results in animal models and human clinical trials before considering clinical use.
This fermentation-assisted enhancement illustrates the growing interest in the microbial biotransformation of natural plant products to bolster pharmacological activity—a field that may yield new adjunct therapies with fewer side effects.
Context and Broader Implications
Stevia has long been valued as a natural zero-calorie sweetener, but these findings expand its potential beyond dietary purposes to medicinal applications. Historically, many cancer treatments originated from plants—such as paclitaxel and vincristine—underscoring the importance of exploring plant-derived compounds.
Given pancreatic cancer’s poor prognosis and increasing incidence, the prospect of a plant-based therapy that selectively targets cancer cells could revolutionize treatment paradigms. If further research confirms safety and efficacy, fermented stevia extract might complement current treatments or offer alternative options for patients unable to tolerate standard chemotherapy.
Limitations and Considerations
It is crucial to recognize the current evidence is limited to in vitro cell studies. The effects of fermented stevia extract have not been tested in animal models or clinical trials. Thus, it remains unknown whether the anticancer compounds can effectively reach tumor sites in the human body or what doses are safe and effective.
Additionally, while stevia extracts show cancer-fighting properties, not all artificial sweeteners have demonstrated such effects. Systematic reviews and extensive epidemiological data so far have not found conclusive links between artificial sweeteners and an increased cancer risk.
Practical Takeaways for Readers
For now, consumers can continue to use stevia as a safe natural sweetener. These emerging scientific insights do not imply that stevia should replace conventional cancer treatments or be consumed in therapeutic doses without medical supervision.
The research highlights the potential of combining natural products with microbial technologies to develop novel therapeutics. Public health advocates and clinicians should monitor ongoing developments while encouraging patients to rely on proven treatments and consult healthcare professionals for personalized cancer care.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
